JVC: Explanation forconsolidated business result in Q2,2013 and Q3, 2013

Japan Vietnam Medical Instrument Joint Stock Companyexplained business result in Q2/2013 and Q3/2013 compared to the same period of 2012 as follows:

-         The consolidated revenue and profit in Q2/2013 increased VND109.58 billion (equivalent to 226%) and VND5.038 billion (equivalent to 357%) respectively compared to the same period of 2012 because the successful acquisition of Kyoto Medial Science Joint Stock Company.

-         The consolidated revenue and profit in Q3/2013decreased by 57% and 88% respectively compared to the same period of 2012 because agreements to supply equipment to administrative units were delayed.Other segments such as joint-venture, service… were not influenced too much but they have a low proportion in revenue structure of JVC.

HOSE

>   SRF: Explanation forconsolidated business result in Q3, 2013 (19/11/2013)

>   PVA: Financial Statement Quarter 3/2013 (Consolidated) (19/11/2013)

>   PVX: Financial Statement Quarter 3/2013 (holding company) (19/11/2013)

>   PVX: Financial Statement Quarter 3/2013 (Consolidated) (19/11/2013)

>   PSG: Financial Statement Quarter 3/2013 (holding company) (19/11/2013)

>   LTC: Financial Statement Quarter 3/2013 (consolidated) (19/11/2013)

>   PSG: Financial Statement Quarter 3/2013 (Consolidated) (18/11/2013)

>   CAN: Change in the Business Registration Certificate (18/11/2013)

>   SJE: Financial Statement Quarter 3/2013 (18/11/2013)

>   SDD: Financial Statement Quarter 3/2013 (18/11/2013)